• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房癌症患者的侵袭性真菌感染。

Invasive fungal infections in patients with cancer in the Intensive Care Unit.

机构信息

Infectious Diseases Unit, Pathophysiology Department, Laikon General Hospital and Medical School, National and Kapodistrian University of Athens, Athens, Greece.

出版信息

Int J Antimicrob Agents. 2012 Jun;39(6):464-71. doi: 10.1016/j.ijantimicag.2011.11.017. Epub 2012 Feb 14.

DOI:10.1016/j.ijantimicag.2011.11.017
PMID:22337064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3855365/
Abstract

Invasive fungal infections (IFIs) have emerged as a major cause of morbidity and mortality amongst critically ill patients. Cancer patients admitted to the Intensive Care Unit (ICU) have multiple risk factors for IFIs. The vast majority of IFIs in the ICU are due to Candida spp. The incidence of invasive candidiasis (IC) has increased over recent decades, especially in the ICU. A shift in the distribution of Candida spp. from Candida albicans to non-albicans Candida spp. has been observed both in ICUs and oncology units in the last two decades. Timely diagnosis of IC remains a challenge despite the introduction of new microbiology techniques. Delayed initiation of antifungal therapy is associated with increased mortality. Therefore, prediction rules have been developed and validated prospectively in order to identify those ICU patients at high risk for IC and likely to benefit from early treatment. These rules, however, have not been validated in cancer patients. Similarly, major clinical studies on the efficacy of newer antifungals typically do not include cancer patients. Despite the introduction of more potent and less toxic antifungals, mortality from IFIs amongst cancer patients remains high. In recent years, aspergillosis and mucormycosis have also emerged as significant causes of morbidity and mortality amongst ICU patients with haematological cancer.

摘要

侵袭性真菌感染(IFI)已成为重症患者发病率和死亡率的主要原因。入住重症监护病房(ICU)的癌症患者有多种IFI 的风险因素。ICU 中绝大多数 IFI 是由念珠菌属引起的。侵袭性念珠菌病(IC)的发病率在最近几十年有所增加,尤其是在 ICU 中。在过去的二十年中,无论是在 ICU 还是肿瘤病房,念珠菌属的分布已经从白色念珠菌转变为非白色念珠菌属念珠菌属。尽管新的微生物学技术已经问世,但 IC 的及时诊断仍然是一个挑战。抗真菌治疗的延迟启动与死亡率增加有关。因此,已经制定并前瞻性验证了预测规则,以确定那些 ICU 患者有发生 IC 的高风险,并可能从早期治疗中受益。然而,这些规则尚未在癌症患者中得到验证。同样,关于新型抗真菌药物疗效的主要临床研究通常不包括癌症患者。尽管引入了更有效和毒性更小的抗真菌药物,但癌症患者的 IFI 死亡率仍然很高。近年来,曲霉菌病和毛霉菌病也已成为血液系统癌症 ICU 患者发病率和死亡率的重要原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d6/3855365/1caadfe3e3ad/nihms530075f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d6/3855365/e03c90a918bb/nihms530075f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d6/3855365/aae377f582f0/nihms530075f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d6/3855365/1caadfe3e3ad/nihms530075f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d6/3855365/e03c90a918bb/nihms530075f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d6/3855365/aae377f582f0/nihms530075f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d6/3855365/1caadfe3e3ad/nihms530075f3.jpg

相似文献

1
Invasive fungal infections in patients with cancer in the Intensive Care Unit.重症监护病房癌症患者的侵袭性真菌感染。
Int J Antimicrob Agents. 2012 Jun;39(6):464-71. doi: 10.1016/j.ijantimicag.2011.11.017. Epub 2012 Feb 14.
2
Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008).重症监护病房侵袭性真菌感染:意大利多中心前瞻性观察研究(2006-2008 年)。
Mycoses. 2012 Jan;55(1):73-9. doi: 10.1111/j.1439-0507.2011.02044.x. Epub 2011 Jun 12.
3
Invasive fungal infections: the challenge continues.侵袭性真菌感染:挑战仍在继续。
Drugs. 2009;69 Suppl 1:65-73. doi: 10.2165/11315530-000000000-00000.
4
Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients.长期重症监护患者的侵袭性真菌感染和(1,3)-β-D-葡聚糖血清浓度。
Int J Infect Dis. 2009 Nov;13(6):707-12. doi: 10.1016/j.ijid.2008.10.013. Epub 2009 Jan 20.
5
Patients at high risk of invasive fungal infections: when and how to treat.侵袭性真菌感染高危患者:何时以及如何进行治疗。
Drugs. 2008;68(14):1941-62. doi: 10.2165/00003495-200868140-00002.
6
Incidence and outcome of fungal infections in pediatric small bowel transplant recipients.小儿小肠移植受者真菌感染的发病率及转归
Transpl Infect Dis. 2010 Dec;12(6):497-504. doi: 10.1111/j.1399-3062.2010.00542.x.
7
Invasive fungal infections in critically ill patients: A prospective study from a tertiary care hospital in India.危重症患者侵袭性真菌感染:来自印度一家三级医疗医院的前瞻性研究。
Drug Discov Ther. 2018;12(6):363-367. doi: 10.5582/ddt.2018.01068.
8
[Invasive fungal infection in critically ill patients].[危重症患者的侵袭性真菌感染]
Enferm Infecc Microbiol Clin. 2012 Jun;30(6):338-43. doi: 10.1016/j.eimc.2012.02.011. Epub 2012 Apr 12.
9
Invasive fungal infections in critically ill children: epidemiology, risk factors and antifungal drugs.危重症儿童侵袭性真菌感染:流行病学、危险因素及抗真菌药物
Drugs Context. 2024 Jun 17;13. doi: 10.7573/dic.2023-9-2. eCollection 2024.
10
[Epidemiological profile and sensitivity pattern of isolates causing invasive fungal infection vs. colonizing isolates in non-neutropenic critically ill patients].[非中性粒细胞减少的重症患者中引起侵袭性真菌感染的分离株与定殖分离株的流行病学特征及敏感性模式]
Rev Iberoam Micol. 2013 Jan 3;30(1):14-20. doi: 10.1016/j.riam.2012.06.003. Epub 2012 Jun 29.

引用本文的文献

1
Novel infection by kills hosts through intestinal perforation.新型感染通过肠道穿孔杀死宿主。 (原句中“by”后缺少具体病原体名称,翻译只能按现有内容进行)
bioRxiv. 2025 Jun 5:2025.06.04.657490. doi: 10.1101/2025.06.04.657490.
2
Diagnosis and treatment of invasive pulmonary aspergillosis in critically ill intensive care patients: executive summary of the German national guideline (AWMF 113-005).重症监护病房危重症患者侵袭性肺曲霉病的诊断与治疗:德国国家指南(AWMF 113 - 005)执行摘要
Infection. 2025 Jun 4. doi: 10.1007/s15010-025-02572-2.
3
Evaluation of epidemiological, clinical, and microbiological features of vulvovaginal candidiasis.

本文引用的文献

1
Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study.β-D-葡聚糖检测对免疫功能低下危重症合并呼吸道感染症状的侵袭性曲霉病的诊断价值:一项基于尸检的研究。
J Clin Microbiol. 2011 Nov;49(11):3783-7. doi: 10.1128/JCM.00879-11. Epub 2011 Aug 31.
2
Ocular manifestations of candidemia.眼内念珠菌病的表现。
Clin Infect Dis. 2011 Aug 1;53(3):262-8. doi: 10.1093/cid/cir355.
3
The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts.
外阴阴道念珠菌病的流行病学、临床及微生物学特征评估
GMS Hyg Infect Control. 2025 Apr 30;20:Doc15. doi: 10.3205/dgkh000544. eCollection 2025.
4
[S1 guideline: diagnosis and treatment of invasive pulmonary aspergillosis in critically ill/intensive care patients].[S1 指南:危重症/重症监护患者侵袭性肺曲霉病的诊断与治疗]
Med Klin Intensivmed Notfmed. 2025 May;120(4):271-289. doi: 10.1007/s00063-025-01265-w. Epub 2025 Mar 21.
5
Optimization of a DNA extraction protocol for improving bacterial and fungal classification based on Nanopore sequencing.优化用于基于纳米孔测序改进细菌和真菌分类的DNA提取方案。
Access Microbiol. 2024 Oct 7;6(10). doi: 10.1099/acmi.0.000754.v3. eCollection 2024.
6
The Prevalence and Risk Factors of Trichosporonosis at King Abdulaziz University Hospital.阿卜杜勒阿齐兹国王大学医院曲霉菌病的患病率及危险因素
Int J Gen Med. 2024 Apr 3;17:1297-1310. doi: 10.2147/IJGM.S449511. eCollection 2024.
7
Unveiling the Hungarian landscape of laboratory and clinical management capacities for invasive fungal infections: navigating the frontlines against fungal menaces.揭示匈牙利侵袭性真菌感染的实验室和临床管理能力现状:应对真菌威胁的前沿探索。
Ther Adv Infect Dis. 2023 Dec 18;10:20499361231219315. doi: 10.1177/20499361231219315. eCollection 2023 Jan-Dec.
8
Invasive Fungal Infections in the Paediatric Intensive Care Unit: A Hong Kong Study.儿科重症监护病房中的侵袭性真菌感染:一项香港研究。
Curr Pediatr Rev. 2024;20(4):540-547. doi: 10.2174/1573396320666230811092915.
9
Fungal mechanisms of intracellular survival: what can we learn from bacterial pathogens?真菌的细胞内生存机制:我们能从细菌病原体中学到什么?
Infect Immun. 2023 Sep 14;91(9):e0043422. doi: 10.1128/iai.00434-22. Epub 2023 Jul 28.
10
Antibodies to Combat Fungal Infections: Development Strategies and Progress.对抗真菌感染的抗体:研发策略与进展
Microorganisms. 2023 Mar 6;11(3):671. doi: 10.3390/microorganisms11030671.
halo 和 reversed halo 征象对合并症宿主侵袭性霉菌感染的诊断价值。
Clin Infect Dis. 2011 May;52(9):1144-55. doi: 10.1093/cid/cir122.
4
β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis.β-D-葡聚糖检测用于侵袭性真菌感染的诊断:一项荟萃分析。
Clin Infect Dis. 2011 Mar 15;52(6):750-70. doi: 10.1093/cid/ciq206.
5
Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study.重症监护病房念珠菌血流感染:重症监护病房研究中感染的广泛流行分析。
Crit Care Med. 2011 Apr;39(4):665-70. doi: 10.1097/CCM.0b013e318206c1ca.
6
Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients.近期接触卡泊芬净或氟康唑影响念珠菌血症的流行病学:一项涉及 2441 例患者的前瞻性多中心研究。
Antimicrob Agents Chemother. 2011 Feb;55(2):532-8. doi: 10.1128/AAC.01128-10. Epub 2010 Nov 15.
7
Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting.外科重症监护病房中(1→3)-β-D-葡聚糖的前瞻性调查及其与侵袭性念珠菌病的关系。
J Clin Microbiol. 2011 Jan;49(1):58-61. doi: 10.1128/JCM.01240-10. Epub 2010 Nov 3.
8
Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials.念珠菌血症患者早期拔除中心静脉导管不能改善预后:来自 2 项随机临床试验的 842 例患者分析。
Clin Infect Dis. 2010 Aug 1;51(3):295-303. doi: 10.1086/653935.
9
Comparison of albicans vs. non-albicans candidemia in French intensive care units.法国重症监护病房白色念珠菌与非白色念珠菌血症的比较。
Crit Care. 2010;14(3):R98. doi: 10.1186/cc9033. Epub 2010 May 27.
10
Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.卡泊芬净在由常见非白念珠菌引起的侵袭性念珠菌病患者中的应用:卡泊芬净数据库综述。
Antimicrob Agents Chemother. 2010 May;54(5):1864-71. doi: 10.1128/AAC.00911-09. Epub 2010 Mar 15.